Annual EBIT
-$28.73 M
+$8.17 M+22.15%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual earnings before interest & taxes is -$28.73 million, with the most recent change of +$8.17 million (+22.15%) on December 31, 2023.
- During the last 3 years, IMNM annual EBIT has fallen by -$10.93 million (-61.40%).
- IMNM annual EBIT is now -272.90% below its all-time high of -$7.70 million, reached on December 31, 2018.
Performance
IMNM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$43.82 M
-$10.12 M-30.03%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly earnings before interest & taxes is -$43.82 million, with the most recent change of -$10.12 million (-30.03%) on September 30, 2024.
- Over the past year, IMNM quarterly EBIT has dropped by -$29.96 million (-216.34%).
- IMNM quarterly EBIT is now -1550.32% below its all-time high of -$2.65 million, reached on March 31, 2020.
Performance
IMNM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$111.71 M
-$39.18 M-54.03%
September 30, 2024
Summary
- As of February 7, 2025, IMNM TTM earnings before interest & taxes is -$111.71 million, with the most recent change of -$39.18 million (-54.03%) on September 30, 2024.
- Over the past year, IMNM TTM EBIT has dropped by -$82.98 million (-288.85%).
- IMNM TTM EBIT is now -4006.95% below its all-time high of -$2.72 million, reached on September 30, 2019.
Performance
IMNM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IMNM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.1% | -216.3% | -288.9% |
| 3 y3 years | -61.4% | -462.7% | -202.7% |
| 5 y5 years | -272.9% | -462.7% | -202.7% |
IMNM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.0% | +22.1% | -880.0% | at low | -392.9% | at low |
| 5 y | 5-year | -177.9% | +22.1% | -1550.3% | at low | -1895.5% | at low |
| alltime | all time | -272.9% | +22.1% | -1550.3% | at low | -4006.9% | at low |
Immunome EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$43.82 M(+30.0%) | -$111.71 M(+54.0%) |
| Jun 2024 | - | -$33.70 M(+65.6%) | -$72.53 M(+62.6%) |
| Mar 2024 | - | -$20.34 M(+46.9%) | -$44.60 M(+55.3%) |
| Dec 2023 | -$28.73 M(-22.1%) | -$13.85 M(+199.0%) | -$28.73 M(+26.8%) |
| Sep 2023 | - | -$4.63 M(-19.7%) | -$22.66 M(-14.7%) |
| Jun 2023 | - | -$5.77 M(+29.1%) | -$26.57 M(-10.6%) |
| Mar 2023 | - | -$4.47 M(-42.6%) | -$29.72 M(-19.5%) |
| Dec 2022 | -$36.90 M(+46.4%) | -$7.79 M(-8.8%) | -$36.90 M(-0.2%) |
| Sep 2022 | - | -$8.53 M(-4.4%) | -$36.96 M(+2.2%) |
| Jun 2022 | - | -$8.93 M(-23.4%) | -$36.15 M(+9.7%) |
| Mar 2022 | - | -$11.65 M(+48.6%) | -$32.96 M(+30.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$25.20 M(+41.6%) | -$7.84 M(+1.6%) | -$25.20 M(+17.7%) |
| Sep 2021 | - | -$7.72 M(+34.5%) | -$21.42 M(-2.9%) |
| Jun 2021 | - | -$5.74 M(+47.3%) | -$22.07 M(+15.9%) |
| Mar 2021 | - | -$3.90 M(-4.1%) | -$19.04 M(+7.0%) |
| Dec 2020 | -$17.80 M(+72.2%) | -$4.06 M(-51.5%) | -$17.80 M(+7.1%) |
| Sep 2020 | - | -$8.37 M(+208.2%) | -$16.61 M(+51.5%) |
| Jun 2020 | - | -$2.71 M(+2.3%) | -$10.97 M(+32.9%) |
| Mar 2020 | - | -$2.65 M(-7.7%) | -$8.25 M(+47.4%) |
| Dec 2019 | -$10.34 M(+34.2%) | -$2.88 M(+5.8%) | -$5.60 M(+105.8%) |
| Sep 2019 | - | -$2.72 M | -$2.72 M |
| Dec 2018 | -$7.70 M | - | - |
FAQ
- What is Immunome annual earnings before interest & taxes?
- What is the all time high annual EBIT for Immunome?
- What is Immunome annual EBIT year-on-year change?
- What is Immunome quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Immunome?
- What is Immunome quarterly EBIT year-on-year change?
- What is Immunome TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Immunome?
- What is Immunome TTM EBIT year-on-year change?
What is Immunome annual earnings before interest & taxes?
The current annual EBIT of IMNM is -$28.73 M
What is the all time high annual EBIT for Immunome?
Immunome all-time high annual earnings before interest & taxes is -$7.70 M
What is Immunome annual EBIT year-on-year change?
Over the past year, IMNM annual earnings before interest & taxes has changed by +$8.17 M (+22.15%)
What is Immunome quarterly earnings before interest & taxes?
The current quarterly EBIT of IMNM is -$43.82 M
What is the all time high quarterly EBIT for Immunome?
Immunome all-time high quarterly earnings before interest & taxes is -$2.65 M
What is Immunome quarterly EBIT year-on-year change?
Over the past year, IMNM quarterly earnings before interest & taxes has changed by -$29.96 M (-216.34%)
What is Immunome TTM earnings before interest & taxes?
The current TTM EBIT of IMNM is -$111.71 M
What is the all time high TTM EBIT for Immunome?
Immunome all-time high TTM earnings before interest & taxes is -$2.72 M
What is Immunome TTM EBIT year-on-year change?
Over the past year, IMNM TTM earnings before interest & taxes has changed by -$82.98 M (-288.85%)